nodes	percent_of_prediction	percent_of_DWPC	metapath
Sorafenib—MAP2K5—restless legs syndrome	0.873	1	CbGaD
Sorafenib—RET—autonomic nervous system—restless legs syndrome	0.00475	0.0532	CbGeAlD
Sorafenib—MAPK15—brainstem—restless legs syndrome	0.00341	0.0382	CbGeAlD
Sorafenib—KDR—hindlimb—restless legs syndrome	0.00327	0.0367	CbGeAlD
Sorafenib—KDR—appendage—restless legs syndrome	0.00281	0.0314	CbGeAlD
Sorafenib—MUSK—nervous system—restless legs syndrome	0.00243	0.0273	CbGeAlD
Sorafenib—ZAK—MAPK Signaling Pathway—MAP2K5—restless legs syndrome	0.00204	0.0534	CbGpPWpGaD
Sorafenib—CDKL2—nervous system—restless legs syndrome	0.00198	0.0222	CbGeAlD
Sorafenib—CDKL2—central nervous system—restless legs syndrome	0.00191	0.0214	CbGeAlD
Sorafenib—MAPK15—nervous system—restless legs syndrome	0.00179	0.02	CbGeAlD
Sorafenib—TAOK2—MAPK Signaling Pathway—MAP2K5—restless legs syndrome	0.00173	0.0454	CbGpPWpGaD
Sorafenib—MAPK15—central nervous system—restless legs syndrome	0.00172	0.0193	CbGeAlD
Sorafenib—CDKL3—brain—restless legs syndrome	0.00166	0.0186	CbGeAlD
Sorafenib—CDKL2—brain—restless legs syndrome	0.00152	0.017	CbGeAlD
Sorafenib—BRAF—Trk receptor signaling mediated by the MAPK pathway—MAP2K5—restless legs syndrome	0.00149	0.0389	CbGpPWpGaD
Sorafenib—CDK7—Cardiac Hypertrophic Response—MAP2K5—restless legs syndrome	0.0014	0.0366	CbGpPWpGaD
Sorafenib—MAPK15—brain—restless legs syndrome	0.00136	0.0153	CbGeAlD
Sorafenib—CSF1R—Differentiation Pathway—TF—restless legs syndrome	0.0011	0.0287	CbGpPWpGaD
Sorafenib—MAPK11—nervous system—restless legs syndrome	0.00106	0.0119	CbGeAlD
Sorafenib—CDK7—nervous system—restless legs syndrome	0.00104	0.0117	CbGeAlD
Sorafenib—RAF1—Trk receptor signaling mediated by the MAPK pathway—MAP2K5—restless legs syndrome	0.00103	0.0269	CbGpPWpGaD
Sorafenib—RALBP1—EGF/EGFR Signaling Pathway—MAP2K5—restless legs syndrome	0.00103	0.0268	CbGpPWpGaD
Sorafenib—AURKC—nervous system—restless legs syndrome	0.00103	0.0115	CbGeAlD
Sorafenib—MAPK11—central nervous system—restless legs syndrome	0.00102	0.0114	CbGeAlD
Sorafenib—RAF1—brainstem—restless legs syndrome	0.001	0.0113	CbGeAlD
Sorafenib—CDK7—central nervous system—restless legs syndrome	0.001	0.0112	CbGeAlD
Sorafenib—CDK7—MicroRNAs in cardiomyocyte hypertrophy—MAP2K5—restless legs syndrome	0.000996	0.0261	CbGpPWpGaD
Sorafenib—AURKC—central nervous system—restless legs syndrome	0.000987	0.0111	CbGeAlD
Sorafenib—EPHA6—nervous system—restless legs syndrome	0.00095	0.0106	CbGeAlD
Sorafenib—MAP3K7—Cardiac Hypertrophic Response—MAP2K5—restless legs syndrome	0.000922	0.0241	CbGpPWpGaD
Sorafenib—HIPK4—brain—restless legs syndrome	0.000918	0.0103	CbGeAlD
Sorafenib—EPHA6—central nervous system—restless legs syndrome	0.000914	0.0102	CbGeAlD
Sorafenib—ZAK—nervous system—restless legs syndrome	0.0009	0.0101	CbGeAlD
Sorafenib—ZAK—central nervous system—restless legs syndrome	0.000867	0.00972	CbGeAlD
Sorafenib—MAP3K19—nervous system—restless legs syndrome	0.000863	0.00967	CbGeAlD
Sorafenib—MAP2K5—brainstem—restless legs syndrome	0.000854	0.00957	CbGeAlD
Sorafenib—MAP3K19—central nervous system—restless legs syndrome	0.000831	0.00931	CbGeAlD
Sorafenib—TIE1—nervous system—restless legs syndrome	0.000823	0.00923	CbGeAlD
Sorafenib—MKNK1—MAPK Signaling Pathway—MAP2K5—restless legs syndrome	0.000812	0.0213	CbGpPWpGaD
Sorafenib—MAPK11—brain—restless legs syndrome	0.000809	0.00907	CbGeAlD
Sorafenib—FGFR1—spinal cord—restless legs syndrome	0.000797	0.00893	CbGeAlD
Sorafenib—CDK7—brain—restless legs syndrome	0.000796	0.00892	CbGeAlD
Sorafenib—TIE1—central nervous system—restless legs syndrome	0.000793	0.00889	CbGeAlD
Sorafenib—TAOK2—brain—restless legs syndrome	0.00079	0.00885	CbGeAlD
Sorafenib—AURKC—brain—restless legs syndrome	0.000784	0.00879	CbGeAlD
Sorafenib—ABCC4—Ectoderm Differentiation—TOX3—restless legs syndrome	0.00076	0.0199	CbGpPWpGaD
Sorafenib—KIT—brainstem—restless legs syndrome	0.000757	0.00848	CbGeAlD
Sorafenib—MAP3K7—spinal cord—restless legs syndrome	0.000754	0.00845	CbGeAlD
Sorafenib—BRAF—Signaling Pathways in Glioblastoma—MAP2K5—restless legs syndrome	0.000736	0.0192	CbGpPWpGaD
Sorafenib—MKNK2—spinal cord—restless legs syndrome	0.000731	0.00819	CbGeAlD
Sorafenib—EPHA6—brain—restless legs syndrome	0.000726	0.00814	CbGeAlD
Sorafenib—MKNK1—spinal cord—restless legs syndrome	0.000722	0.00809	CbGeAlD
Sorafenib—RET—spinal cord—restless legs syndrome	0.000713	0.00799	CbGeAlD
Sorafenib—RAF1—Cardiac Hypertrophic Response—MAP2K5—restless legs syndrome	0.000701	0.0183	CbGpPWpGaD
Sorafenib—ZAK—brain—restless legs syndrome	0.000688	0.00771	CbGeAlD
Sorafenib—HIPK3—brain—restless legs syndrome	0.000673	0.00755	CbGeAlD
Sorafenib—FLT1—Focal Adhesion—MAP2K5—restless legs syndrome	0.000663	0.0173	CbGpPWpGaD
Sorafenib—RALBP1—spinal cord—restless legs syndrome	0.00066	0.0074	CbGeAlD
Sorafenib—MAP3K19—brain—restless legs syndrome	0.00066	0.00739	CbGeAlD
Sorafenib—FGFR1—Signaling Pathways in Glioblastoma—MAP2K5—restless legs syndrome	0.000635	0.0166	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways in Glioblastoma—MAP2K5—restless legs syndrome	0.000634	0.0166	CbGpPWpGaD
Sorafenib—TIE1—brain—restless legs syndrome	0.000629	0.00705	CbGeAlD
Sorafenib—FLT1—spinal cord—restless legs syndrome	0.000628	0.00704	CbGeAlD
Sorafenib—BRAF—Integrin-mediated Cell Adhesion—MAP2K5—restless legs syndrome	0.000628	0.0164	CbGpPWpGaD
Sorafenib—RAF1—spinal cord—restless legs syndrome	0.000624	0.007	CbGeAlD
Sorafenib—HTR2C—brainstem—restless legs syndrome	0.000623	0.00698	CbGeAlD
Sorafenib—EPHB6—spinal cord—restless legs syndrome	0.000621	0.00696	CbGeAlD
Sorafenib—MKNK2—nervous system—restless legs syndrome	0.000616	0.0069	CbGeAlD
Sorafenib—MKNK1—nervous system—restless legs syndrome	0.000608	0.00682	CbGeAlD
Sorafenib—BRAF—ErbB1 downstream signaling—MAP2K5—restless legs syndrome	0.000604	0.0158	CbGpPWpGaD
Sorafenib—BRAF—brain—restless legs syndrome	0.000603	0.00676	CbGeAlD
Sorafenib—RET—nervous system—restless legs syndrome	0.000601	0.00673	CbGeAlD
Sorafenib—MKNK2—central nervous system—restless legs syndrome	0.000593	0.00665	CbGeAlD
Sorafenib—PDGFRA—spinal cord—restless legs syndrome	0.000588	0.00659	CbGeAlD
Sorafenib—MKNK1—central nervous system—restless legs syndrome	0.000586	0.00656	CbGeAlD
Sorafenib—RET—central nervous system—restless legs syndrome	0.000578	0.00648	CbGeAlD
Sorafenib—EPHX2—brain—restless legs syndrome	0.000577	0.00646	CbGeAlD
Sorafenib—PDGFRB—Signaling Pathways in Glioblastoma—MAP2K5—restless legs syndrome	0.000571	0.0149	CbGpPWpGaD
Sorafenib—RALBP1—nervous system—restless legs syndrome	0.000556	0.00623	CbGeAlD
Sorafenib—KIT—Differentiation Pathway—TF—restless legs syndrome	0.000549	0.0144	CbGpPWpGaD
Sorafenib—RALBP1—central nervous system—restless legs syndrome	0.000536	0.006	CbGeAlD
Sorafenib—MAP2K5—spinal cord—restless legs syndrome	0.000531	0.00595	CbGeAlD
Sorafenib—KDR—spinal cord—restless legs syndrome	0.000531	0.00595	CbGeAlD
Sorafenib—FLT1—nervous system—restless legs syndrome	0.000529	0.00593	CbGeAlD
Sorafenib—RAF1—nervous system—restless legs syndrome	0.000526	0.0059	CbGeAlD
Sorafenib—EPHB6—nervous system—restless legs syndrome	0.000523	0.00586	CbGeAlD
Sorafenib—FLT4—brain—restless legs syndrome	0.00052	0.00583	CbGeAlD
Sorafenib—CSF1R—spinal cord—restless legs syndrome	0.000518	0.00581	CbGeAlD
Sorafenib—RET—SIDS Susceptibility Pathways—TF—restless legs syndrome	0.000516	0.0135	CbGpPWpGaD
Sorafenib—FGFR1—brain—restless legs syndrome	0.000513	0.00575	CbGeAlD
Sorafenib—FLT1—central nervous system—restless legs syndrome	0.000509	0.00571	CbGeAlD
Sorafenib—RAF1—Signaling Pathways in Glioblastoma—MAP2K5—restless legs syndrome	0.000509	0.0133	CbGpPWpGaD
Sorafenib—RAF1—central nervous system—restless legs syndrome	0.000506	0.00568	CbGeAlD
Sorafenib—EPHB6—central nervous system—restless legs syndrome	0.000504	0.00564	CbGeAlD
Sorafenib—STK10—nervous system—restless legs syndrome	0.000501	0.00561	CbGeAlD
Sorafenib—RAF1—MicroRNAs in cardiomyocyte hypertrophy—MAP2K5—restless legs syndrome	0.000499	0.0131	CbGpPWpGaD
Sorafenib—PDGFRA—nervous system—restless legs syndrome	0.000496	0.00556	CbGeAlD
Sorafenib—MAP3K7—brain—restless legs syndrome	0.000486	0.00544	CbGeAlD
Sorafenib—STK10—central nervous system—restless legs syndrome	0.000482	0.0054	CbGeAlD
Sorafenib—PDGFRA—central nervous system—restless legs syndrome	0.000477	0.00535	CbGeAlD
Sorafenib—MKNK2—brain—restless legs syndrome	0.000471	0.00528	CbGeAlD
Sorafenib—KIT—spinal cord—restless legs syndrome	0.00047	0.00527	CbGeAlD
Sorafenib—MKNK1—brain—restless legs syndrome	0.000465	0.00521	CbGeAlD
Sorafenib—PDGFRB—spinal cord—restless legs syndrome	0.000459	0.00515	CbGeAlD
Sorafenib—RET—brain—restless legs syndrome	0.000459	0.00515	CbGeAlD
Sorafenib—MAP2K5—nervous system—restless legs syndrome	0.000447	0.00501	CbGeAlD
Sorafenib—KDR—nervous system—restless legs syndrome	0.000447	0.00501	CbGeAlD
Sorafenib—KDR—Focal Adhesion—MAP2K5—restless legs syndrome	0.000441	0.0115	CbGpPWpGaD
Sorafenib—CSF1R—nervous system—restless legs syndrome	0.000436	0.00489	CbGeAlD
Sorafenib—MAPK11—Insulin Signaling—MAP2K5—restless legs syndrome	0.000435	0.0114	CbGpPWpGaD
Sorafenib—RAF1—Integrin-mediated Cell Adhesion—MAP2K5—restless legs syndrome	0.000434	0.0114	CbGpPWpGaD
Sorafenib—MAP2K5—central nervous system—restless legs syndrome	0.000431	0.00483	CbGeAlD
Sorafenib—KDR—central nervous system—restless legs syndrome	0.000431	0.00483	CbGeAlD
Sorafenib—BRAF—EGF/EGFR Signaling Pathway—MAP2K5—restless legs syndrome	0.000427	0.0112	CbGpPWpGaD
Sorafenib—RAF1—Ion channel transport—FXYD1—restless legs syndrome	0.000426	0.0111	CbGpPWpGaD
Sorafenib—RALBP1—brain—restless legs syndrome	0.000425	0.00477	CbGeAlD
Sorafenib—CSF1R—central nervous system—restless legs syndrome	0.00042	0.00471	CbGeAlD
Sorafenib—RAF1—ErbB1 downstream signaling—MAP2K5—restless legs syndrome	0.000418	0.0109	CbGpPWpGaD
Sorafenib—BRAF—MAPK Signaling Pathway—MAP2K5—restless legs syndrome	0.000414	0.0108	CbGpPWpGaD
Sorafenib—FLT1—brain—restless legs syndrome	0.000404	0.00453	CbGeAlD
Sorafenib—RAF1—brain—restless legs syndrome	0.000402	0.00451	CbGeAlD
Sorafenib—EPHB6—brain—restless legs syndrome	0.0004	0.00448	CbGeAlD
Sorafenib—ABCG2—Iron uptake and transport—TF—restless legs syndrome	0.000397	0.0104	CbGpPWpGaD
Sorafenib—KIT—nervous system—restless legs syndrome	0.000396	0.00444	CbGeAlD
Sorafenib—MAP3K7—Insulin Signaling—MAP2K5—restless legs syndrome	0.000392	0.0103	CbGpPWpGaD
Sorafenib—HTR2C—spinal cord—restless legs syndrome	0.000387	0.00434	CbGeAlD
Sorafenib—PDGFRB—nervous system—restless legs syndrome	0.000387	0.00434	CbGeAlD
Sorafenib—STK10—brain—restless legs syndrome	0.000383	0.00429	CbGeAlD
Sorafenib—KIT—central nervous system—restless legs syndrome	0.000382	0.00428	CbGeAlD
Sorafenib—PDGFRA—brain—restless legs syndrome	0.000379	0.00425	CbGeAlD
Sorafenib—MAP3K7—MAPK Signaling Pathway—MAP2K5—restless legs syndrome	0.000377	0.00987	CbGpPWpGaD
Sorafenib—BRAF—Focal Adhesion—MAP2K5—restless legs syndrome	0.000376	0.00983	CbGpPWpGaD
Sorafenib—PDGFRB—central nervous system—restless legs syndrome	0.000373	0.00418	CbGeAlD
Sorafenib—FGFR1—MAPK Signaling Pathway—MAP2K5—restless legs syndrome	0.000358	0.00937	CbGpPWpGaD
Sorafenib—MAPK11—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.000355	0.0093	CbGpPWpGaD
Sorafenib—BRAF—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.000352	0.00921	CbGpPWpGaD
Sorafenib—MAP2K5—brain—restless legs syndrome	0.000342	0.00383	CbGeAlD
Sorafenib—KDR—brain—restless legs syndrome	0.000342	0.00383	CbGeAlD
Sorafenib—CSF1R—brain—restless legs syndrome	0.000334	0.00374	CbGeAlD
Sorafenib—ABCC4—Platelet degranulation—TF—restless legs syndrome	0.00033	0.00863	CbGpPWpGaD
Sorafenib—HTR2C—nervous system—restless legs syndrome	0.000326	0.00366	CbGeAlD
Sorafenib—RAF1—BDNF signaling pathway—MAP2K5—restless legs syndrome	0.000324	0.00849	CbGpPWpGaD
Sorafenib—PDGFRA—Focal Adhesion—MAP2K5—restless legs syndrome	0.000324	0.00847	CbGpPWpGaD
Sorafenib—PDGFRB—MAPK Signaling Pathway—MAP2K5—restless legs syndrome	0.000322	0.00842	CbGpPWpGaD
Sorafenib—KIT—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.00032	0.00839	CbGpPWpGaD
Sorafenib—HTR2C—central nervous system—restless legs syndrome	0.000314	0.00352	CbGeAlD
Sorafenib—ABCC4—Response to elevated platelet cytosolic Ca2+—TF—restless legs syndrome	0.000314	0.00822	CbGpPWpGaD
Sorafenib—ABCC4—nervous system—restless legs syndrome	0.000308	0.00345	CbGeAlD
Sorafenib—HTR2B—nervous system—restless legs syndrome	0.000307	0.00344	CbGeAlD
Sorafenib—FGFR1—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.000304	0.00796	CbGpPWpGaD
Sorafenib—PDGFRA—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.000303	0.00794	CbGpPWpGaD
Sorafenib—KIT—brain—restless legs syndrome	0.000303	0.0034	CbGeAlD
Sorafenib—RAF1—Insulin Signaling—MAP2K5—restless legs syndrome	0.000298	0.0078	CbGpPWpGaD
Sorafenib—ABCC4—central nervous system—restless legs syndrome	0.000297	0.00333	CbGeAlD
Sorafenib—PDGFRB—brain—restless legs syndrome	0.000296	0.00332	CbGeAlD
Sorafenib—RAF1—EGF/EGFR Signaling Pathway—MAP2K5—restless legs syndrome	0.000295	0.00772	CbGpPWpGaD
Sorafenib—HTR2B—central nervous system—restless legs syndrome	0.000295	0.00331	CbGeAlD
Sorafenib—PDGFRB—Focal Adhesion—MAP2K5—restless legs syndrome	0.000292	0.00763	CbGpPWpGaD
Sorafenib—RAF1—MAPK Signaling Pathway—MAP2K5—restless legs syndrome	0.000287	0.0075	CbGpPWpGaD
Sorafenib—CYP2D6—brainstem—restless legs syndrome	0.000285	0.00319	CbGeAlD
Sorafenib—ABCG2—HIF-1-alpha transcription factor network—TF—restless legs syndrome	0.000282	0.00738	CbGpPWpGaD
Sorafenib—MAPK11—Signaling by NGF—MAP2K5—restless legs syndrome	0.000273	0.00715	CbGpPWpGaD
Sorafenib—PDGFRB—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.000273	0.00715	CbGpPWpGaD
Sorafenib—BRAF—Signaling by NGF—MAP2K5—restless legs syndrome	0.000271	0.00709	CbGpPWpGaD
Sorafenib—RAF1—Focal Adhesion—MAP2K5—restless legs syndrome	0.00026	0.0068	CbGpPWpGaD
Sorafenib—ABCG2—spinal cord—restless legs syndrome	0.000258	0.00289	CbGeAlD
Sorafenib—HTR2C—brain—restless legs syndrome	0.000249	0.0028	CbGeAlD
Sorafenib—KIT—Signaling by NGF—MAP2K5—restless legs syndrome	0.000246	0.00645	CbGpPWpGaD
Sorafenib—RAF1—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.000244	0.00637	CbGpPWpGaD
Sorafenib—ABCC4—brain—restless legs syndrome	0.000236	0.00264	CbGeAlD
Sorafenib—HTR2B—brain—restless legs syndrome	0.000234	0.00263	CbGeAlD
Sorafenib—FGFR1—Signaling by NGF—MAP2K5—restless legs syndrome	0.000234	0.00612	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling by NGF—MAP2K5—restless legs syndrome	0.000233	0.00611	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling by NGF—MAP2K5—restless legs syndrome	0.00021	0.0055	CbGpPWpGaD
Sorafenib—CYP2B6—nervous system—restless legs syndrome	0.000201	0.00225	CbGeAlD
Sorafenib—CYP2B6—central nervous system—restless legs syndrome	0.000193	0.00217	CbGeAlD
Sorafenib—RAF1—Signaling by NGF—MAP2K5—restless legs syndrome	0.000187	0.0049	CbGpPWpGaD
Sorafenib—MAPK11—Glucocorticoid receptor regulatory network—POMC—restless legs syndrome	0.000183	0.00478	CbGpPWpGaD
Sorafenib—ABCC4—Transmembrane transport of small molecules—FXYD1—restless legs syndrome	0.000176	0.00461	CbGpPWpGaD
Sorafenib—CYP2C8—brain—restless legs syndrome	0.000171	0.00192	CbGeAlD
Sorafenib—ABCG2—brain—restless legs syndrome	0.000166	0.00186	CbGeAlD
Sorafenib—BRAF—Corticotropin-releasing hormone—POMC—restless legs syndrome	0.000165	0.00432	CbGpPWpGaD
Sorafenib—CYP2B6—brain—restless legs syndrome	0.000153	0.00172	CbGeAlD
Sorafenib—ABCB1—HIF-1-alpha transcription factor network—TF—restless legs syndrome	0.000152	0.00399	CbGpPWpGaD
Sorafenib—CYP3A4—nervous system—restless legs syndrome	0.000152	0.0017	CbGeAlD
Sorafenib—CYP2D6—nervous system—restless legs syndrome	0.000149	0.00167	CbGeAlD
Sorafenib—ABCC2—Transmembrane transport of small molecules—FXYD1—restless legs syndrome	0.000149	0.00389	CbGpPWpGaD
Sorafenib—RAF1—Transmembrane transport of small molecules—FXYD1—restless legs syndrome	0.000148	0.00388	CbGpPWpGaD
Sorafenib—ABCC4—Platelet activation, signaling and aggregation—TF—restless legs syndrome	0.000146	0.00383	CbGpPWpGaD
Sorafenib—CYP3A4—central nervous system—restless legs syndrome	0.000146	0.00164	CbGeAlD
Sorafenib—CYP2D6—central nervous system—restless legs syndrome	0.000144	0.00161	CbGeAlD
Sorafenib—RALBP1—Signaling Pathways—MAP2K5—restless legs syndrome	0.00014	0.00366	CbGpPWpGaD
Sorafenib—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—restless legs syndrome	0.000139	0.00364	CbGpPWpGaD
Sorafenib—FLT4—Signaling Pathways—MAP2K5—restless legs syndrome	0.000138	0.0036	CbGpPWpGaD
Sorafenib—ABCG2—Transmembrane transport of small molecules—FXYD1—restless legs syndrome	0.000129	0.00338	CbGpPWpGaD
Sorafenib—ABCB1—spinal cord—restless legs syndrome	0.000127	0.00143	CbGeAlD
Sorafenib—RAF1—Platelet activation, signaling and aggregation—TF—restless legs syndrome	0.000123	0.00322	CbGpPWpGaD
Sorafenib—RAF1—Corticotropin-releasing hormone—POMC—restless legs syndrome	0.000114	0.00299	CbGpPWpGaD
Sorafenib—CYP2D6—brain—restless legs syndrome	0.000114	0.00128	CbGeAlD
Sorafenib—MKNK1—Signaling Pathways—MAP2K5—restless legs syndrome	0.000114	0.00298	CbGpPWpGaD
Sorafenib—CYP3A7—Phase 1 - Functionalization of compounds—POMC—restless legs syndrome	0.000113	0.00295	CbGpPWpGaD
Sorafenib—ABCB1—nervous system—restless legs syndrome	0.000107	0.0012	CbGeAlD
Sorafenib—ABCB1—central nervous system—restless legs syndrome	0.000103	0.00116	CbGeAlD
Sorafenib—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—restless legs syndrome	0.000103	0.00269	CbGpPWpGaD
Sorafenib—FLT1—Signaling Pathways—MAP2K5—restless legs syndrome	0.000103	0.00269	CbGpPWpGaD
Sorafenib—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—restless legs syndrome	0.0001	0.00263	CbGpPWpGaD
Sorafenib—EPHX2—Metabolism of lipids and lipoproteins—POMC—restless legs syndrome	9.23e-05	0.00242	CbGpPWpGaD
Sorafenib—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—restless legs syndrome	8.7e-05	0.00228	CbGpPWpGaD
Sorafenib—CYP2B6—Phase 1 - Functionalization of compounds—POMC—restless legs syndrome	8.33e-05	0.00218	CbGpPWpGaD
Sorafenib—ABCB1—brain—restless legs syndrome	8.2e-05	0.000919	CbGeAlD
Sorafenib—CYP3A5—Phase 1 - Functionalization of compounds—POMC—restless legs syndrome	8.14e-05	0.00213	CbGpPWpGaD
Sorafenib—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—restless legs syndrome	7.76e-05	0.00203	CbGpPWpGaD
Sorafenib—ABCC4—Hemostasis—TF—restless legs syndrome	7.54e-05	0.00197	CbGpPWpGaD
Sorafenib—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—restless legs syndrome	7.14e-05	0.00187	CbGpPWpGaD
Sorafenib—UGT1A1—Biological oxidations—POMC—restless legs syndrome	7.11e-05	0.00186	CbGpPWpGaD
Sorafenib—UGT1A9—Biological oxidations—POMC—restless legs syndrome	7.11e-05	0.00186	CbGpPWpGaD
Sorafenib—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—restless legs syndrome	7.08e-05	0.00185	CbGpPWpGaD
Sorafenib—CYP2C8—Phase 1 - Functionalization of compounds—POMC—restless legs syndrome	7.05e-05	0.00185	CbGpPWpGaD
Sorafenib—ABCB1—Transmembrane transport of small molecules—FXYD1—restless legs syndrome	6.99e-05	0.00183	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—MAP2K5—restless legs syndrome	6.83e-05	0.00179	CbGpPWpGaD
Sorafenib—ABCC4—Transmembrane transport of small molecules—TF—restless legs syndrome	6.53e-05	0.00171	CbGpPWpGaD
Sorafenib—RAF1—Hemostasis—TF—restless legs syndrome	6.34e-05	0.00166	CbGpPWpGaD
Sorafenib—CYP2C19—Phase 1 - Functionalization of compounds—POMC—restless legs syndrome	6.29e-05	0.00165	CbGpPWpGaD
Sorafenib—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—restless legs syndrome	6.05e-05	0.00158	CbGpPWpGaD
Sorafenib—CYP3A7—Biological oxidations—POMC—restless legs syndrome	5.98e-05	0.00157	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—MAP2K5—restless legs syndrome	5.87e-05	0.00154	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—MAP2K5—restless legs syndrome	5.82e-05	0.00152	CbGpPWpGaD
Sorafenib—CYP2D6—Phase 1 - Functionalization of compounds—POMC—restless legs syndrome	5.79e-05	0.00152	CbGpPWpGaD
Sorafenib—CYP2C9—Phase 1 - Functionalization of compounds—POMC—restless legs syndrome	5.74e-05	0.0015	CbGpPWpGaD
Sorafenib—ABCC2—Transmembrane transport of small molecules—TF—restless legs syndrome	5.5e-05	0.00144	CbGpPWpGaD
Sorafenib—RAF1—Transmembrane transport of small molecules—TF—restless legs syndrome	5.49e-05	0.00144	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—MAP2K5—restless legs syndrome	5.29e-05	0.00139	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—MAP2K5—restless legs syndrome	5.29e-05	0.00139	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—MAP2K5—restless legs syndrome	5.02e-05	0.00131	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—MAP2K5—restless legs syndrome	5.01e-05	0.00131	CbGpPWpGaD
Sorafenib—CYP1A2—Phase 1 - Functionalization of compounds—POMC—restless legs syndrome	4.9e-05	0.00128	CbGpPWpGaD
Sorafenib—ABCG2—Transmembrane transport of small molecules—TF—restless legs syndrome	4.79e-05	0.00125	CbGpPWpGaD
Sorafenib—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—restless legs syndrome	4.67e-05	0.00122	CbGpPWpGaD
Sorafenib—HTR2B—Class A/1 (Rhodopsin-like receptors)—POMC—restless legs syndrome	4.59e-05	0.0012	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—MAP2K5—restless legs syndrome	4.51e-05	0.00118	CbGpPWpGaD
Sorafenib—CYP2B6—Biological oxidations—POMC—restless legs syndrome	4.42e-05	0.00116	CbGpPWpGaD
Sorafenib—CYP3A5—Biological oxidations—POMC—restless legs syndrome	4.33e-05	0.00113	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—MAP2K5—restless legs syndrome	4.31e-05	0.00113	CbGpPWpGaD
Sorafenib—EPHX2—Metabolism—POMC—restless legs syndrome	4.11e-05	0.00108	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—MAP2K5—restless legs syndrome	4.02e-05	0.00105	CbGpPWpGaD
Sorafenib—CYP3A4—Phase 1 - Functionalization of compounds—POMC—restless legs syndrome	3.79e-05	0.000991	CbGpPWpGaD
Sorafenib—CYP2C8—Biological oxidations—POMC—restless legs syndrome	3.75e-05	0.00098	CbGpPWpGaD
Sorafenib—HTR2C—Class A/1 (Rhodopsin-like receptors)—POMC—restless legs syndrome	3.7e-05	0.000968	CbGpPWpGaD
Sorafenib—HTR2B—GPCR ligand binding—POMC—restless legs syndrome	3.49e-05	0.000914	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—MAP2K5—restless legs syndrome	3.47e-05	0.000909	CbGpPWpGaD
Sorafenib—RALBP1—Signaling Pathways—POMC—restless legs syndrome	3.44e-05	0.0009	CbGpPWpGaD
Sorafenib—FLT4—Signaling Pathways—POMC—restless legs syndrome	3.38e-05	0.000885	CbGpPWpGaD
Sorafenib—CYP2C19—Biological oxidations—POMC—restless legs syndrome	3.34e-05	0.000875	CbGpPWpGaD
Sorafenib—CYP2D6—Biological oxidations—POMC—restless legs syndrome	3.08e-05	0.000805	CbGpPWpGaD
Sorafenib—CYP2C9—Biological oxidations—POMC—restless legs syndrome	3.05e-05	0.000798	CbGpPWpGaD
Sorafenib—HTR2C—GPCR ligand binding—POMC—restless legs syndrome	2.82e-05	0.000737	CbGpPWpGaD
Sorafenib—MKNK1—Signaling Pathways—POMC—restless legs syndrome	2.8e-05	0.000733	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism of lipids and lipoproteins—POMC—restless legs syndrome	2.73e-05	0.000715	CbGpPWpGaD
Sorafenib—CYP1A2—Biological oxidations—POMC—restless legs syndrome	2.61e-05	0.000682	CbGpPWpGaD
Sorafenib—ABCB1—Transmembrane transport of small molecules—TF—restless legs syndrome	2.59e-05	0.000677	CbGpPWpGaD
Sorafenib—FLT1—Signaling Pathways—POMC—restless legs syndrome	2.52e-05	0.00066	CbGpPWpGaD
Sorafenib—CYP3A4—Biological oxidations—POMC—restless legs syndrome	2.01e-05	0.000526	CbGpPWpGaD
Sorafenib—HTR2B—GPCR downstream signaling—POMC—restless legs syndrome	1.97e-05	0.000517	CbGpPWpGaD
Sorafenib—HTR2B—Signaling by GPCR—POMC—restless legs syndrome	1.79e-05	0.000469	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—POMC—restless legs syndrome	1.72e-05	0.000451	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—POMC—restless legs syndrome	1.68e-05	0.000439	CbGpPWpGaD
Sorafenib—RAF1—Signaling by GPCR—POMC—restless legs syndrome	1.68e-05	0.000438	CbGpPWpGaD
Sorafenib—HTR2C—GPCR downstream signaling—POMC—restless legs syndrome	1.59e-05	0.000417	CbGpPWpGaD
Sorafenib—HTR2C—Signaling by GPCR—POMC—restless legs syndrome	1.45e-05	0.000378	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—POMC—restless legs syndrome	1.44e-05	0.000378	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism of lipids and lipoproteins—POMC—restless legs syndrome	1.44e-05	0.000376	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—POMC—restless legs syndrome	1.43e-05	0.000374	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—POMC—restless legs syndrome	1.3e-05	0.000341	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—POMC—restless legs syndrome	1.3e-05	0.000341	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism of lipids and lipoproteins—POMC—restless legs syndrome	1.28e-05	0.000336	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—POMC—restless legs syndrome	1.24e-05	0.000323	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—POMC—restless legs syndrome	1.23e-05	0.000323	CbGpPWpGaD
Sorafenib—UGT1A1—Metabolism—POMC—restless legs syndrome	1.22e-05	0.000318	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism—POMC—restless legs syndrome	1.22e-05	0.000318	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism of lipids and lipoproteins—POMC—restless legs syndrome	1.17e-05	0.000306	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—POMC—restless legs syndrome	1.11e-05	0.000291	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—POMC—restless legs syndrome	1.06e-05	0.000277	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—POMC—restless legs syndrome	1.03e-05	0.00027	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—POMC—restless legs syndrome	1.02e-05	0.000268	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism of lipids and lipoproteins—POMC—restless legs syndrome	1e-05	0.000262	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—POMC—restless legs syndrome	9.9e-06	0.000259	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—POMC—restless legs syndrome	8.54e-06	0.000224	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—POMC—restless legs syndrome	7.57e-06	0.000198	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—POMC—restless legs syndrome	7.4e-06	0.000194	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—POMC—restless legs syndrome	6.41e-06	0.000168	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—POMC—restless legs syndrome	5.72e-06	0.00015	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—POMC—restless legs syndrome	5.58e-06	0.000146	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—POMC—restless legs syndrome	5.26e-06	0.000138	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—POMC—restless legs syndrome	5.21e-06	0.000136	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—POMC—restless legs syndrome	4.46e-06	0.000117	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—POMC—restless legs syndrome	3.44e-06	9e-05	CbGpPWpGaD
